Company Overview
- Website
- eliksa.com
- Employees
- 4
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
PABC announces winner of $250,000 investment
- Jul 25, 2024
- buckscountyherald.com
Social Determinants of Health (SDOH) and Context in Initial Access, Symptom Report, and Recovery within Pediatric Mild Traumatic Brain Injury (mTBI) Care (P10-8.004)
- Apr 16, 2024
- neurology.org
Evaluating the Use and Efficacy of Avonex and Plegridy in Pediatric Patients (P11-6.005)
- Apr 9, 2024
- neurology.org
A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19
- Dec 8, 2023
- bmcinfectdis.biomedcentral.com
Efficacy and Safety of Processed Amniotic Fluid (pAF) Drops for the Treatment of Ocular Chronic Graft-Versus-Host Disease
- Nov 2, 2023
- sciencedirect.com
KeifeRx Appoints Garrett Vygantas to Board of Directors
- Feb 14, 2023
- firstwordpharma.com
Who is Eliksa Therapeutics
Eliksa Therapeutics is a small, venture-backed biotechnology company based in Philadelphia, Pennsylvania. With a team of three employees, Eliksa focuses on developing innovative therapies for unmet medical needs in the ocular and cardiovascular fields. The company's primary product, ELK-003, is a novel biological designed to modulate inflammation, cell recovery, and tissue healing. ELK-003 targets multiple pathways, offering a unique approach to treating various ocular and cardiovascular conditions. Eliksa Therapeutics stands out due to its proprietary cGMP production facility, ensuring high-quality and consistent manufacturing of its therapeutic candidates. The company also boasts a robust clinical pipeline, demonstrating its commitment to advancing promising treatments through rigorous clinical trials. For more information about Eliksa Therapeutics and its innovative therapies, visit their website at eliksa.com.
Eliksa Therapeutics Industry Tags
Companies Similar to Eliksa Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Eliksa Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |